More on ENMD
Data
Financials
News
Click line-items for a historical chart and %
| Royalties | |
| Other | |
| Revenues, Total | |
| Research and development | 1.01M |
| General and administrative | 676.93K |
| Acquired In-Process R&D | |
| Costs and Expenses, Total | 1.69M |
| Interest expense | |
| Other income (expense) | |
| Net Loss | -1.69M |
| Dividends on Series A convertible preferred stock | |
| Net loss attributable to common shareholders | |
| Net loss per share (basic and diluted) | -0.03 |
| Weighted average number of common shares outstanding (basic and diluted) | |
Entities mentioned with ENMD
- Earnings | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Citi | View Related Stories »
- Dividend | View Related Stories »
- Morning Movers | View Related Stories »
- Amgen/Micromet | View Related Stories »
- Needham & Company | View Related Stories »
- Bayside Capital Partners/Majestic Capital | View Related Stories »
- Show More...
